| On September 1st, the efficacy and safety of | | | | provide substantial evidence of a growing benefit |
| vagus nerve stimulation for depresssion was | | | | of VNS Therapy over time when other |
| published in the prestigious peer reviewed journal | | | | treatments have not worked or have stopped |
| of Biological Psychiatry.The data from the pivotal | | | | working. This is particularly encouraging given the |
| clinical trial of vagus nerve stimulation and | | | | nature of treatment-resistant depression, a |
| depression was been on published September 1st, | | | | devastating and difficult to treat condition."The |
| in the prestigious peer-reviewed journal of | | | | publication of these articles is very important to |
| Biological Psychiatry. There were three articles | | | | you because third party payers (private insurance |
| published in Biological Psychiatry about VNS | | | | companies, Medicare, etc.) will help facilitate the |
| Therapy and depression. The articles confirm the | | | | approval of reimbursement of VNS Therapy for |
| association of VNS Therapy with significant | | | | depression. Although reimbursement decisions will |
| antidepressant benefits that are sustained and/or | | | | continue to be on a case-by-case basis, this is a |
| growing over one year for patients with chronic | | | | critical next step which will be viewed very |
| or recurrent treatment-resistant depression. | | | | positively by insurance companies, Medicare as |
| Secondly, the long-term safety of the procedure | | | | well as your psychiatrist.You can learn more about |
| was confirmed."The response and remission and | | | | this remarkable treatment at There is a free |
| sustained long-term benefits realized by the | | | | newsletter to keep you up-to-date on the latest |
| patients treated with adjunctive VNS Therapy is | | | | developments on this first ever FDA approved |
| remarkable, given that participants in the trials | | | | long term treatment option for chronic or |
| were some of the most treatment-resistant, | | | | recurrent depression.Charles Donovan was a |
| depressed patients ever studied, with at least half | | | | study study subject in the FDA investigational trial |
| having been hospitalized for the disease at least | | | | of vagus nerve stimulation and chronic depression. |
| once," commented Dr. A. John Rush, MD, | | | | He is the author of: Out of the Black Hole: The |
| Professor and Vice Chairman for Research, | | | | Patient's Guide to Vagus Nerve Stimulation and |
| Department of Psychiatry, Betty Jo Hay Chair in | | | | Depression and founder of the Web site.Out of |
| Mental Health, Rosewood Corporation Chair in | | | | the Black Hole: The Patient's Guide to Vagus |
| Biomedical Science, University of Texas | | | | Nerve Stimulation and Depression is available on |
| Southwestern Medical Center, Dallas, TX. "The | | | | Amazon. |
| VNS studies presented in these publications | | | | |